mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.003 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.004 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.004 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.006 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.008 |